Clinical trial / 2009
Sublingual vitamin B12 reduced outbreak duration, ulcer count, and pain level in recurrent aphthous stomatitis.
In a randomized, double-blind, placebo-controlled trial, 58 primary care patients with recurrent aphthous stomatitis received either 1000 mcg sublingual vitamin B12 (n=31) or placebo (n=27) for 6 months. Outbreak duration, number of ulcers, and pain level were reduced significantly (P < .05) at 5 and 6 months of vitamin B12 treatment, regardless of initial blood vitamin B12 levels. During the last month, significantly more participants in the intervention group achieved 'no aphthous ulcers status' compared to control (74.1% vs 32.0%; P < .01).
- Study type
- Randomized, double-blind, placebo-controlled trial
- Who was studied
- 58 primary care patients suffering from recurrent aphthous stomatitis
- What was measured
- Duration of outbreaks, number of ulcers, pain level, and no aphthous ulcers status
THE PAPER
Effectiveness of vitamin B12 in treating recurrent aphthous stomatitis: a randomized, double-blind, placebo-controlled trial.
Volkov I, Rudoy I, Freud T, Sardal G, Naimer S, Peleg R, Press Y. J Am Board Fam Med, 2009.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.